Recurrent Pancreatic Adenocarcinoma
5 clinical trials · Condition
◉ Watch Recurrent Pancreatic Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer (NCT03910387) | Emory University | 2019-04-17 |
| Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer (NCT02907099) | M.D. Anderson Cancer Center | 2016-12-01 |
Track Recurrent Pancreatic Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.